Laura Esserman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS) (NCT02872025) | Laura Esserman | 2016-12-12 |
Track Laura Esserman automatically
Every clearance here is in the API, with alerts when new ones post.